AIG
ATOS icon

American International Group’s Atossa Therapeutics ATOS Stock Holding History

American International Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,872
Closed -$73K – 3101
2022
Q1 		$73K Sell
3,872
-273
-7% -$5.55K ﹤0.01% 2710
2021
Q4 		$99K Sell
4,145
-124
-3% -$4.54K ﹤0.01% 2719
2021
Q3 		$209K Sell
4,269
-101
-2% -$5.88K ﹤0.01% 2407
2021
Q2 		$414K Buy
+4,370
New +$231K ﹤0.01% 2048

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American International Group's ATOS Position: Q2 2022 in Review

American International Group sold out of Atossa Therapeutics (ATOS) in Q2 2022, closing a stake of 3,872 shares — an estimated $73K sold.

American International Group first reported a position in ATOS in Q2 2021 and held it in 4 quarters. The position peaked at $414K in Q2 2021. 73 funds tracked by Wall St. Rank hold ATOS as of Q2 2022.

  • American International Group reported no remaining Atossa Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 3,872 Atossa Therapeutics shares in Q2 2022, an estimated $73K.
  • American International Group first reported a position in Atossa Therapeutics in Q2 2021 and held it in 4 quarters.
  • American International Group's Atossa Therapeutics position peaked at $414K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.